Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
Saved in:
| Title: | Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. |
|---|---|
| Authors: | Semitala FC; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda., Kadota JL; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Musinguzi A; Infectious Diseases Research Collaboration, Kampala, Uganda., Nabunje J; Infectious Diseases Research Collaboration, Kampala, Uganda., Welishe F; Infectious Diseases Research Collaboration, Kampala, Uganda., Nakitende A; Infectious Diseases Research Collaboration, Kampala, Uganda., Akello L; Infectious Diseases Research Collaboration, Kampala, Uganda., Bishop O; Infectious Diseases Research Collaboration, Kampala, Uganda., Patel D; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America., Sammann A; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America., Nahid P; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Belknap R; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America., Kamya MR; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda., Handley MA; Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America., Phillips PPJ; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Katahoire A; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Berger CA; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America., Kiwanuka N; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda., Katamba A; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda., Dowdy DW; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America., Cattamanchi A; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda. |
| Source: | PLoS medicine [PLoS Med] 2021 Dec 16; Vol. 18 (12), pp. e1003875. Date of Electronic Publication: 2021 Dec 16 (Print Publication: 2021). |
| Publication Type: | Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Pragmatic Clinical Trial |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34914696 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Semitala+FC%22">Semitala FC</searchLink>; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Kadota+JL%22">Kadota JL</searchLink>; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Musinguzi+A%22">Musinguzi A</searchLink>; Infectious Diseases Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Nabunje+J%22">Nabunje J</searchLink>; Infectious Diseases Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Welishe+F%22">Welishe F</searchLink>; Infectious Diseases Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Nakitende+A%22">Nakitende A</searchLink>; Infectious Diseases Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Akello+L%22">Akello L</searchLink>; Infectious Diseases Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Bishop+O%22">Bishop O</searchLink>; Infectious Diseases Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Patel+D%22">Patel D</searchLink>; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Sammann+A%22">Sammann A</searchLink>; The Better Lab, Department of Surgery, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Nahid+P%22">Nahid P</searchLink>; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Belknap+R%22">Belknap R</searchLink>; Denver Health and Hospital Authority and Division of Infectious Diseases, Department of Medicine, University of Colorado, Denver, Colorado, United States of America.<br /><searchLink fieldCode="AU" term="%22Kamya+MR%22">Kamya MR</searchLink>; Makerere University, Department of Medicine, College of Health Sciences, Kampala, Uganda.; Infectious Diseases Research Collaboration, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Handley+MA%22">Handley MA</searchLink>; Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, San Francisco, California, United States of America.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Phillips+PPJ%22">Phillips PPJ</searchLink>; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Katahoire+A%22">Katahoire A</searchLink>; Child Health and Development Center, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Berger+CA%22">Berger CA</searchLink>; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Kiwanuka+N%22">Kiwanuka N</searchLink>; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Katamba+A%22">Katamba A</searchLink>; Clinical Epidemiology & Biostatistics Unit, Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Dowdy+DW%22">Dowdy DW</searchLink>; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Cattamanchi+A%22">Cattamanchi A</searchLink>; UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California, United States of America.; Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101231360%22">PLoS medicine</searchLink> [PLoS Med] 2021 Dec 16; Vol. 18 (12), pp. e1003875. <i>Date of Electronic Publication: </i>2021 Dec 16 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Pragmatic Clinical Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101231360 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-1676 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215491277%22">15491277 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34914696 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pmed.1003875 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1003875 Titles: – TitleFull: Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Semitala FC – PersonEntity: Name: NameFull: Kadota JL – PersonEntity: Name: NameFull: Musinguzi A – PersonEntity: Name: NameFull: Nabunje J – PersonEntity: Name: NameFull: Welishe F – PersonEntity: Name: NameFull: Nakitende A – PersonEntity: Name: NameFull: Akello L – PersonEntity: Name: NameFull: Bishop O – PersonEntity: Name: NameFull: Patel D – PersonEntity: Name: NameFull: Sammann A – PersonEntity: Name: NameFull: Nahid P – PersonEntity: Name: NameFull: Belknap R – PersonEntity: Name: NameFull: Kamya MR – PersonEntity: Name: NameFull: Handley MA – PersonEntity: Name: NameFull: Phillips PPJ – PersonEntity: Name: NameFull: Katahoire A – PersonEntity: Name: NameFull: Berger CA – PersonEntity: Name: NameFull: Kiwanuka N – PersonEntity: Name: NameFull: Katamba A – PersonEntity: Name: NameFull: Dowdy DW – PersonEntity: Name: NameFull: Cattamanchi A IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 12 Text: 2021 Dec 16 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1549-1676 Numbering: – Type: volume Value: 18 – Type: issue Value: 12 Titles: – TitleFull: PLoS medicine Type: main |
| ResultId | 1 |
